- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06356558
Adapting Enhanced Recovery Programs for Low Health Literacy Patients
June 25, 2026 updated by: Daniel Chu, University of Alabama at Birmingham
Low health literacy patients are a vulnerable population at high-risk for surgical disparities including longer hospital stays, more complications, and more readmissions.
This study will adapt enhanced recovery programs (ERPs) to low health literacy patients with a multilevel, health literacy-based implementation strategy (called VISACT - VISuAl aids, Coach providers in communication, and Train organizations in health literacy) to improve ERP fidelity and thereby outcomes.
In the final aim of this project (Specific Aim 3), the VISACT intervention will be tested in a pilot trial.
Findings from this study will lay the foundation for a multi-institutional stepped-wedge trial and establish key principles for adapting interventions to eliminate disparities.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Rationale: Low health literacy affects over a third of surgical populations and is associated with significantly worse outcomes in surgery.
Interventions that reduce disparities in this large population are urgently needed.
Previous work has shown that enhanced recovery programs (ERPs) mitigate racial disparities in surgical outcomes and offer a pragmatic way to address surgical disparities.
Existing ERPs, however, work poorly for patients with low health literacy who still experience worse outcomes.
This gap arises from the lack of fit between current ERPs and the needs of low health literacy patients.
Prior work through a K23 grant assessed these needs and developed a novel multilevel strategy to improve fit: engage patients with VISuAl aids, Coach providers in communication, and Train organizations in health literacy (VISACT).
An opportunity now exists to deliver and test the VISACT using a theory-based adaptation framework.
Successful adaptations would transform existing ERPs and broaden its disparity-reducing impact to low health literacy populations.
Objectives: The long-term objective is to eliminate disparities and improve outcomes for low health literacy populations in surgery through context-driven adaptations of existing ERPs.
The hypothesis is that VISACT will improve fidelity to ERP's components for low health literacy patients and thereby surgical outcomes.
To achieve this objective, the aims are: (SA1) identify the health literacy-sensitive components of ERPs to augment with VISACT, (SA2) assess the health literacy needs of providers and organizational units on ERP teams, and (SA3) deliver and pilot test the VISACT implementation strategy on existing ERPs.
Methods: First, guided by the Dynamics Adaptation Process framework, machine learning on a large ERP database (n>7,000) will be used to identify the health literacy-sensitive components of ERPs to augment with VISACT (SA1).
Second, a convergent mixed-methods integrative approach will be used to identify gaps in health literacy knowledge, best practices, and preparedness to adapt on ERP implementation teams through three interrelated methods: in vivo observations of ERPs in-action at 4 Alabama facilities, extended semi-structured interviews of 120 stakeholders, and surveys measuring health literacy knowledge and organizational preparedness to adapt.
Third, the VISACT intervention will be tested at two sites in Alabama (urban and rural) through a novel interactive response platform in a pilot study and assessed for feasibility/acceptability through a RE-AIM framework of reach, efficacy, adoption, implementation, and maintenance measures.
Acquired data will inform design of a multi-institutional stepped-wedge trial of the VISACT in the Deep South.
Significance: This study will advance the NIH/NIMHD mission to eliminate surgical disparities and responds directly to the NIMHD Science Visioning Research Strategies by removing health literacy barriers (#24) and building the science of adapting interventions to different contexts (#30).
The project will furthermore (i) deliver the first health literate intervention in surgery, (ii) establish a novel implementation strategy (VISACT) to address surgical disparities and (iii) advance the science of interventions through adaptations.
Study Type
Interventional
Enrollment (Estimated)
1050
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Daniel I Chu, MD
- Phone Number: 205-975-1932
- Email: dchu@uab.edu
Study Contact Backup
- Name: Kaycee Hair
- Phone Number: 205-975-1932
- Email: khair@uabmc.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- Recruiting
- University of Alabama at Birmingham
-
Contact:
- Daniel I Chu, MD
- Phone Number: 205-975-1932
- Email: dchu@uab.edu
-
Contact:
- Kaycee Hair
- Phone Number: 205-975-1932
- Email: khair@uabmc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adult patients >= 18 years of age undergoing surgery under an enhanced recovery program (ERPs)
- Adult caregivers/providers, organizational leaders, >= 18 years of age with direct or indirect involvement with ERP implementation
- All genders
- All race/ethnicities
- Able to consent
- English-speaking
Exclusion Criteria:
- Child (<18 years of age)
- Patients undergoing operations not included under ERPs
- Participants unable to consent for the study
- Participants whose mental state excludes them from being able to understand contents of the informed consent form and/or patients whose family members or patient representative do not wish for them to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pre-Post Arm
The overall pilot trial will last for 2.5 years at 2 sites. For each of the 2 sites:
|
The intervention is an implementation strategy called VISACT: VISuAl aids, Coach providers in communication, and Train organizations in health literacy.
This strategy will be delivered to patients, providers, and organizations through a novel interactive response platform.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reach - the primary outcome will be to assess the reach of the intervention (VISACT) on patients and providers.
Time Frame: 16-24 months
|
Percentage of patient and provider participants who are exposed to the intervention (VISACT) per month.
|
16-24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacy - Length-of-stay of index surgical hospitalization
Time Frame: 16-24 months
|
Total days (d) in the hospital for index surgical hospitalization.
|
16-24 months
|
|
Adoption - Completion rate of the intervention (VISACT) by participants per month
Time Frame: 16-24 months
|
Percentage (%) of patient and provider participants who complete the intervention (VISACT) per month.
|
16-24 months
|
|
Implementation - Fidelity rate of patients with components of the Enhanced Recovery Program
Time Frame: 16-24 months
|
Percentage (%) of components of the Enhanced Recovery Program completed by participants.
This will be reported, for example, as 5 out of 15 components (33% adherence) or 15 out of 15 components (100% adherence).
Higher fidelity will indicate high-quality implementation of the program.
|
16-24 months
|
|
Maintenance - Long-term adoption rate of the intervention (VISACT) per year
Time Frame: 16-24 months
|
Percentage (%) of patient and provider participants who complete the intervention (VISACT) per year.
|
16-24 months
|
|
Efficacy - Readmission rate
Time Frame: 16-24 months
|
Percentage (%) of readmissions 30-days after discharge from hospital (# of readmissions/# of discharge patients per month)
|
16-24 months
|
|
Efficacy - Complications rate
Time Frame: 16-24 months
|
Percentage (%) of patients with one or more post-operative complications
|
16-24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Daniel I Chu, MD, University of Alabama at Birmingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 15, 2026
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
May 1, 2028
Study Registration Dates
First Submitted
March 25, 2024
First Submitted That Met QC Criteria
April 4, 2024
First Posted (Actual)
April 10, 2024
Study Record Updates
Last Update Posted (Actual)
June 29, 2026
Last Update Submitted That Met QC Criteria
June 25, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300010279
- R01CA271303 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No immediate plan to share except as de-identified data to NIH.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
MedtronicCompletedThoracic Surgery | Spine Surgery | Upper Extremity Surgery | Lower Extremity Surgery | Intracranial Surgery | Extracranial Surgery | Intratemporal Surgery | Extratemporal Surgery | Neck SurgeryGermany
-
[Redacted]3M; Solventum US LLCWithheldAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingAnesthesia, Local | Foot Surgery | Hand Surgery | Walant SurgeryFrance
-
Baylor Research InstituteChiesi USA, Inc.CompletedSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Maquet Cardiopulmonary GmbHNAMSATerminatedCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain, Italy
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Eurosets S.r.l.RecruitingCardiac Surgery | Cardiopulmonary Bypass | Heart Surgery | Aortic Valve Surgery | Cannulation | Coronary Surgery With Cardiopulmonary Bypass | Coronary Surgery | Arterial Cannulation | Venous CannulationItaly
Clinical Trials on Educational intervention (VISACT)
-
CellSight Technologies, Inc.Oregon Health and Science University; Stanford UniversityTerminatedCorrelate Tracer Uptake to TCell Tumor Infiltration & CkIT BenefitUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBacterial Infection | Clostridium DifficileUnited States
-
Universidad de GranadaNot yet recruitingAsthma | Allergy
-
Roswell Park Cancer InstituteCompletedCervical Cancer | Breast CancerUnited States
-
US Department of Veterans AffairsDuke UniversityCompletedAccidental FallsUnited States
-
Gary MorrowNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
McGill University Health Centre/Research Institute...University of Manitoba; Sunnybrook Health Sciences Centre; University of Alberta and other collaboratorsCompletedPeptic Ulcer Hemorrhage
-
Azienda Unita Sanitaria Locale Reggio EmiliaCompletedMelanoma (Skin) | Educational ProblemsItaly
-
Goethe UniversityUnknownHealth Knowledge, Attitudes, PracticeGermany
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedBreast Cancer | LymphedemaUnited States